Endotoxin Validation

Endotoxin Validation is a methodological process within pharmaceutical and biomedical quality assurance that verifies the effectiveness of procedures designed to detect, remove, or inactivate endotoxins, distinguishing it from general contamination control by its specific focus on the detection and quantification of lipopolysaccharide components of Gram-negative bacterial cell walls.

50

Publications

1.7K

Citations

209

Authors

76

Institutions

Publications per year

2017–2026

7

Authors

209

  1. JF
    James Fenimore Cooper

    Medical University of South Carolina, United States

    2 publications · 62 citations

    2

    h-index

  2. JH
    James H. Jorgensen

    The University of Texas at San Antonio Health Science Center, United States

    2 publications · 109 citations

    2

    h-index

  3. TJ
    Thomas J. Novitsky

    Boston Children's Hospital, United States

    2 publications · 40 citations

    2

    h-index

  4. SP
    Stephen Poole

    National Institute for Biological Standards and Control, United Kingdom

    2 publications · 68 citations

    2

    h-index

  5. ME
    M E Weary

    Charles River Laboratories (Netherlands), Netherlands

    2 publications · 65 citations

    2

    h-index

1–5 of 209

Venues

  1. PubMed

    Repository · 10 publications · 260 citations

    10

    h-index

  2. Applied Microbiology

    3 publications · 179 citations

    3

    h-index

  3. Cytotherapy

    2 publications · 71 citations

    2

    h-index

  4. Journal of Translational Medicine

    JTM · 2 publications · 65 citations

    2

    h-index

  5. Applied and Environmental Microbiology

    AEM · 2 publications · 100 citations

    2

    h-index

1–5